This inventor holds 10 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 4 EPO patents. Top assignee: Siemens Healthcare Diagnostics Gmbh. Active years: 2010-2024.
Location History:
- Roslindale, MA (US) (2010)
- Berkeley, CA (US) (2012 - 2024)
Company Filing History:
Years Active: 2010-2024
Title: Arejas Uzgiris: Innovator in HCV Detection
Introduction
Arejas Uzgiris is a prominent inventor based in Berkeley, CA (US). He has made significant contributions to the field of healthcare diagnostics, particularly in the detection of Hepatitis C Virus (HCV). With a total of 10 patents to his name, Uzgiris has established himself as a key figure in medical innovation.
Latest Patents
Uzgiris's latest patents focus on reagents and methods for detecting HCV. The present disclosure relates to oligonucleotide sequences for amplification primers and their use in performing nucleic acid amplifications of HCV, specifically in regions that encode the NS3 polypeptide. In some embodiments, the primers are utilized in nested PCR methods for the detection or sequencing of HCV NS3. The oligonucleotide sequences are also provided assembled as kits that can be used to amplify and detect or sequence HCV NS3.
Career Highlights
Uzgiris is currently associated with Siemens Healthcare Diagnostics GmbH, where he continues to innovate in the field of diagnostics. His work has been instrumental in advancing the methodologies used for HCV detection, contributing to improved healthcare outcomes.
Collaborations
Some of his notable coworkers include Sunil Pandit and Lance Palmer, who have collaborated with Uzgiris on various projects aimed at enhancing diagnostic techniques.
Conclusion
Arejas Uzgiris is a distinguished inventor whose work in HCV detection has made a significant impact in the field of healthcare diagnostics. His innovative approaches and collaborations continue to drive advancements in medical technology.